Global Cryptococcosis Drugs Market Size, Share and Forecast 2021-2027
The global cryptococcosis drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Cryptococcosis is a fungus caused by Cryptococcus neoformans and Cryptococcus gattii that mostly affects the central nervous system and lungs. People with weaker immune systems, such as those with AIDS, Hodgkin lymphoma, other lymphomas, sarcoidosis, and solid organ transplantation, are more susceptible to this type of infection. Inhalation of dust containing yeast cells is the most common way to contract cryptococcosis, which usually affects the lungs. Fever, malaise, cough, hemoptysis (bloody or blood-tinged sputum), headache, visual abnormalities (blurry or double vision, photophobia), and other symptoms are all signs of cryptococcosis. The diagnosis of cryptococcosis is clinical and microscopic, with culture or fixed-tissue staining confirming the diagnosis.
To Request a Sample of our Report on Global
Cryptococcosis Drugs Market: https://www.omrglobal.com/request-sample/cryptococcosis-drugs-market
Globally, roughly one million cases of
cryptococcosis are recorded each year, resulting in around 625,000 fatalities,
according to the United Nations Program on HIV/AIDS and the World Health
Organization. According to the Centers for Disease Control and Prevention and
the World Health Organization, 220,000 instances of cryptococcal meningitis
occur each year among HIV/AIDS patients globally, resulting in over 181,000
mortalities. As a result of the rising frequency of cryptococcosis and the
availability of advanced therapy, the cryptococcosis disorders market is
expected to rise. In the projected years, however, unfavourable effects
connected with the usage of medication are likely to hinder the market growth.
Flucytosine is a water-soluble nucleoside analogue
antifungal medication that works by inhibiting pyrimidine metabolism in the
nucleus of the fungal cell. Flucytosine is commonly used in combination with
other antifungal drugs as a first-line treatment. As it is used as a first-line
treatment in conjunction with other antifungal drugs, flucytosine was a
substantial revenue holding sector. Globally, roughly one million cases of
cryptococcosis are recorded each year, resulting in around 625,000 fatalities,
according to the United Nations Program on HIV/AIDS and the WHO. The rising
prevalence of cryptococcosis, as well as the availability of novel and enhanced
treatment options, are driving the cryptococcosis market.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Bristol
Myers Squibb Co., Pfizer Inc., Janssen Biotech Inc., Bristol-Myers Squibb
Company, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Cryptococcosis Drugs Market is Available at: https://www.omrglobal.com/industry-reports/cryptococcosis-drugs-market
Global Cryptococcosis Drugs Market Report Segmentation
By Treatment
• Amphotericin B
• Flucytosine
• Fluconazole
• Others
Global Cryptococcosis Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment